1. Home
  2. ALDX
  3. ALDX News

Latest Aldeyra Therapeutics Inc. (ALDX) News on October 19, 2025

US High Growth Tech Stocks To Watch For Potential Expansion
ALDX

Simply Wall St.

2 days ago

US High Growth Tech Stocks To Watch For Potential Expansion

Exploring 3 High Growth Tech Stocks in the US Market
ALDX

Simply Wall St.

3 days ago

Exploring 3 High Growth Tech Stocks in the US Market

High Growth US Tech Stocks To Watch In October 2025
ALDX

Simply Wall St.

5 days ago

High Growth US Tech Stocks To Watch In October 2025

High Growth Tech Stocks in US Market for October 2025
ALDX

Simply Wall St.

10 days ago

High Growth Tech Stocks in US Market for October 2025

US High Growth Tech Stocks to Watch in October 2025
ALDX

Simply Wall St.

12 days ago

US High Growth Tech Stocks to Watch in October 2025

High Growth Tech Stocks in US to Watch for Potential Portfolio Boost
ALDX

Simply Wall St.

13 days ago

High Growth Tech Stocks in US to Watch for Potential Portfolio Boost

Exploring High Growth Tech Stocks In The US Market September 2025
ALDX

Simply Wall St.

a month ago

Exploring High Growth Tech Stocks In The US Market September 2025

High Growth Tech Stocks In The US Market September 2025
ALDX

Simply Wall St.

a month ago

High Growth Tech Stocks In The US Market September 2025

Alkermes Appoints Joshua Reed as Chief Financial Officer
ALDX

PR Newswire

a month ago

Alkermes Appoints Joshua Reed as Chief Financial Officer

Exploring High Growth Tech Stocks in the US Market
ALDX

Simply Wall St.

a month ago

Exploring High Growth Tech Stocks in the US Market

ALDX

MT Newswires

3 months ago

Aldeyra Therapeutics Application for Dry Eye Treatment Accepted by FDA

ALDX

Business Wire

3 months ago

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease

5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
ALDX

Zacks

3 months ago

5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats

Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?
ALDX

Zacks

3 months ago

Aldeyra Therapeutics (ALDX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Are Medical Stocks Lagging Amgen (AMGN) This Year?
ALDX

Zacks

3 months ago

Are Medical Stocks Lagging Amgen (AMGN) This Year?

ALDX

MT Newswires

4 months ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Amid Chipmaker Optimism, Eyes Turn to Fed Leadership Speculation

ALDX

MT Newswires

4 months ago

Aldeyra Therapeutics Receives FDA Special Protocol Assessment Agreement for ADX-2191 Trial

ALDX

Business Wire

4 months ago

Aldeyra Therapeutics Receives Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 for the Treatment of Primary Vitreoretinal Lymphoma

ALDX

MT Newswires

4 months ago

Aldeyra Therapeutics Resubmits New Drug Application For Dry Eye Drug; Shares Up Pre-Bell

ALDX

Business Wire

4 months ago

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

June 2025's Spotlight On Promising Penny Stocks
ALDX

Simply Wall St.

4 months ago

June 2025's Spotlight On Promising Penny Stocks

ALDX

Business Wire

5 months ago

Aldeyra Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven?
ALDX

Simply Wall St.

5 months ago

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX): When Will It Breakeven?

ALDX

Business Wire

5 months ago

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Chamber Trial of Reproxalap and Plans NDA Resubmission

ALDX

Business Wire

5 months ago

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Topline Results from Phase 3 Dry Eye Disease Clinical Trials of Reproxalap

ALDX

Business Wire

6 months ago

Aldeyra Therapeutics Appoints Chip Clark to Board of Directors

3 Promising Penny Stocks With Market Caps Under $600M
ALDX

Simply Wall St.

6 months ago

3 Promising Penny Stocks With Market Caps Under $600M

ALDX

MT Newswires

6 months ago

Top Midday Decliners

Aldeyra Therapeutics Stock Craters to All-Time Low on FDA Letter
ALDX

Investopedia

7 months ago

Aldeyra Therapeutics Stock Craters to All-Time Low on FDA Letter

ALDX

MT Newswires

7 months ago

Aldeyra Therapeutics Gets US FDA Letter for Resubmission of New Drug Application for Eye Disease Treatment - Shares Slump Pre-Bell

ALDX

Business Wire

7 months ago

Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease

High Growth Tech Stocks To Watch In The US March 2025
ALDX

Simply Wall St.

7 months ago

High Growth Tech Stocks To Watch In The US March 2025

ALDX

Business Wire

7 months ago

Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference

ALDX

Business Wire

8 months ago

Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

Is Aldeyra Therapeutics (ALDX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?
ALDX

Insider Monkey

9 months ago

Is Aldeyra Therapeutics (ALDX) Among Billionaire Joseph Edelman’s Long-Term Stock Picks?

3 US Penny Stocks With Market Caps Over $80M To Watch
ALDX

Simply Wall St.

10 months ago

3 US Penny Stocks With Market Caps Over $80M To Watch

High Growth Tech Stocks To Watch In December 2024
ALDX

Simply Wall St.

10 months ago

High Growth Tech Stocks To Watch In December 2024

Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?
ALDX

Zacks

10 months ago

Is the Options Market Predicting a Spike in Aldeyra Therapeutics (ALDX) Stock?

ALDX

Business Wire

a year ago

Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference

Top US Penny Stocks To Watch In November 2024
ALDX

Simply Wall St.

a year ago

Top US Penny Stocks To Watch In November 2024

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
ALDX

Zacks

a year ago

ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap

ALDX

MT Newswires

a year ago

Aldeyra Therapeutics' Resubmitted Marketing Application for Eye Disease Drug Accepted by FDA

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease, Expands AbbVie Option Agreement

ALDX

Business Wire

a year ago

Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?
ALDX

Zacks

a year ago

Is BellRing Brands (BRBR) Outperforming Other Medical Stocks This Year?

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting

ALDX

MT Newswires

a year ago

Aldeyra Therapeutics Resubmits New Drug Application for Dry Eye Disease Treatment Candidate

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease

ALDX

Business Wire

a year ago

Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

High Growth Tech Stocks To Watch In The United States
ALDX

Simply Wall St.

a year ago

High Growth Tech Stocks To Watch In The United States

Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory
ALDX

Insider Monkey

a year ago

Aldeyra Therapeutics Inc (NASDAQ:ALDX) A Bull Case Theory

Aldeyra’s Phase III clinical trial of Reproxalap meets primary endpoint
ALDX

Clinical Trials Arena

a year ago

Aldeyra’s Phase III clinical trial of Reproxalap meets primary endpoint

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
ALDX

Business Wire

a year ago

Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap

Owning 36% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),
ALDX

Simply Wall St.

a year ago

Owning 36% shares,institutional owners seem interested in Aldeyra Therapeutics, Inc. (NASDAQ:ALDX),

Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable
ALDX

Business Wire

a year ago

Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable

Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial
ALDX

Clinical Trials Arena

a year ago

Aldeyra Therapeutics concludes subject enrolment in dry eye disease trial

Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
ALDX

Business Wire

a year ago

Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease

ALDX

Business Wire

a year ago

Aldeyra Therapeutics to Host Investor Roundtable Q&A

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
ALDX

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
ALDX

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
ALDX

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
ALDX

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

ALDX

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
ALDX

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool
ALDX

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
ALDX

Simply Wall St.

a year ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

ALDX

Business Wire

a year ago

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?
ALDX

Zacks

a year ago

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?

ALDX

MT Newswires

a year ago

Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study

ALDX

Business Wire

a year ago

Aldeyra Therapeutics Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
ALDX

Business Wire

a year ago

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?
ALDX

Zacks

a year ago

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

ALDX

Business Wire

2 years ago

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why
ALDX

Zacks

2 years ago

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
ALDX

Zacks

2 years ago

Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?

Health Care Roundup: Market Talk
ALDX

The Wall Street Journal

2 years ago

Health Care Roundup: Market Talk

Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval
ALDX

Barrons.com

2 years ago

Aldeyra's Dry Eye Disease Drug May Be on Path for FDA Approval

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner
ALDX

Simply Wall St.

2 years ago

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner

ALDX

Business Wire

2 years ago

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease

Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares
ALDX

GuruFocus.com

2 years ago

Aldeyra Therapeutics Inc President and CEO Todd Brady Sells Company Shares

Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
ALDX

Zacks

2 years ago

Here's Why You Should Invest in Aldeyra (ALDX) Stock Now

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
ALDX

Zacks

2 years ago

Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics
ALDX

Zacks

2 years ago

Zacks Industry Outlook Highlights United Therapeutics, Esperion Therapeutics., Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics

5 Small Drug Stocks to Buy From a Rebounding Industry
ALDX

Zacks

2 years ago

5 Small Drug Stocks to Buy From a Rebounding Industry

Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company
ALDX

Simply Wall St.

2 years ago

Institutions own 37% of Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares but retail investors control 37% of the company

ALDX

Business Wire

2 years ago

Aldeyra Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Orchid Island Capital, Inc. (NYSE:ORC) Q4 2023 Earnings Call Transcript
ALDX

Insider Monkey

2 years ago

Orchid Island Capital, Inc. (NYSE:ORC) Q4 2023 Earnings Call Transcript

ALDX

Associated Press Finance

2 years ago

Waterstone: Q4 Earnings Snapshot

AdTheorent Recognized as Leading Innovator in Frost Radar™ Featuring Demand-Side Platforms
ALDX

PR Newswire

2 years ago

AdTheorent Recognized as Leading Innovator in Frost Radar™ Featuring Demand-Side Platforms

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results
ALDX

Business Wire

2 years ago

Sierra Bancorp Reports Strategic Securities Transaction as Well as Fourth Quarter and Year End 2023 Results

Ramaco Resources (NASDAQ:METC) Is Increasing Its Dividend To $0.1375
ALDX

Simply Wall St.

2 years ago

Ramaco Resources (NASDAQ:METC) Is Increasing Its Dividend To $0.1375

ALDX

GuruFocus.com

2 years ago

South Plains Financial Inc. Reports Mixed Results Amid Economic Challenges

ALDX

Associated Press Finance

2 years ago

South Plains Financial: Q4 Earnings Snapshot

South Plains Financial, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results
ALDX

GlobeNewswire

2 years ago

South Plains Financial, Inc. Reports Fourth Quarter and Year-End 2023 Financial Results

ALDX

Associated Press Finance

2 years ago

Northfield: Q4 Earnings Snapshot

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors
ALDX

GlobeNewswire

2 years ago

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

McEwen (MUX) Loses -13.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ALDX

Zacks

2 years ago

McEwen (MUX) Loses -13.83% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS
ALDX

CNW Group

2 years ago

CANOPY GROWTH KICKS OFF THE NEW YEAR WITH NEW PRODUCTS FROM TWEED, 7ACRES, AND SPECTRUM THERAPEUTICS

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks
ALDX

StockStory

2 years ago

Unpacking Q3 Earnings: BJ's (NASDAQ:BJRI) In The Context Of Other Sit-Down Dining Stocks

Share on Social Networks: